|Place of Origin:||China|
|Certification:||ISO 9001, USP,GMP|
|Minimum Order Quantity:||Negotiation|
|Packaging Details:||Well disguised package ;Foil bag|
|Delivery Time:||3~5 work days|
|Payment Terms:||Western Union, MoneyGram, T/T,Bitcoin|
|Product Name:||Flibanserin||Other Name:||Female|
|Specification:||100mg Orals||Appearance:||White Powder|
|Category:||Female Sexdrugs||Contact Whatsapp:||+8613027196769|
natural male enhancement supplements,
male enhancement products
Product name: Flibanserin
Molecular formula: C20H21F3N4O
Molecular weight: 390.4
Packing: 1KG/ Foil Bag
Appearance: White powder
Grade: Pharmaceutical grade
Usage: Adrug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD)
Flibanserin (INN, USAN), sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication increases the number of satisfying sexual events per month by about one half to one over placebo from a starting point of about two to three.
Flibanserin ( Addyi ) is a new drug being investigated for the prevention of HSDD in woman. HSDD, is a relatively new term developed to describe Hypoactive Sexual Desire Disorder which basically means a woman whose is otherwise healthy has a lacking libido, or a lack of sexual desire. Studies show that about 10-20% of women face this problem and some say HSDD outnumbers men with sexual problems.
Flibanserin is classified as a 5-HT serotonin receptor agonist and a dopamine D4 receptor partial agonist. It is a Non-Hormonal agent that in essence increases dopamine and noradrenalin while reducing Serotonin in the brain. This in return seemingly has a positive effect on a woman's sexual craving who was otherwise lacking in this area. The benefits of it being Non-Hormonal are that it will not have the problems associated with other hormonal treatments such as a negative altered mood among other issues.
|Appearance||white crystals or crystalline powder, has a faint, characteristic odor
and bitter taste
|Solubility||freely soluble in water and 95%ethanol, sparingly soluble in acetic anhydride and practically insoluble in diethyl ether|
|1, red to dark purple color appears|
|2, light red precipitate formed with reinecke salt TS|
|3, UV spectrum meet the reference|
|4, solution (1%) responds to the qualitative test for chloride|
|Melting point||139-143 celcius degree|
|Clarity and color of solution||clear and colorless|
|Heavy metals||10ppm max|
|Organic acid(0.1M NaOH)||0.54ml max|
|Loss on drying||0.5% max|
|Residue on ignition||0.1%max|
|Residual organic Solvents (GC)||Xylol 0.217%max|
|Total impurity 1.5%max|
|Free P-chloro phenoxy acetic 0.5%max|
Count of bacteria
|bacillus 1000/1g max|
|Mildew 100/1g max|
|Microzyme 100/1g max|
A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling. "
It's called the "little pink pill, " a tiny tablet that could have a huge impact on treating female sexual dysfunction. If it's approved, it would become the first drug of its kind on the market.
(1) Recommended dosage is 100 mg taken once daily at bedtime.
(2) Taking it at night reduces the risk of sleepiness, low blood pressure, and fainting during waking hours.
(3) If your symptoms do not improve after 8 weeks of treatment, stop treatment and call your doctor.
(4) If a dose is missed at bedtime, take the next dose at bedtime the following day. Do not take a double dose to make up for a missed one.
Hot selling products
|T3 Na Liothyronine sodium Cytomel CAS: 55-06-1
Stanolone CAS: 521-18-6
Metandienone Dianabol CAS: 72-63-9
Dextromethorphan Hydrobromide CAS: 125-69-9
Methenolone Acetate CAS: 434-05-9
1, 3-Dimethylpentylamine CAS: 105-41-9
Methenolone Enanthate CAS: 303-42-4
Boldenone Undecylenate EQ CAS: 13103-34-9
Drostanolone propionate CAS: 521-12-0
Drostanolone Enanthate CAS: 472-61-145
Yohimbine Hydrochloride CAS: 65-19-0
1, 3 - dimethyleamine hydrochloride
Male sex enhancement products
|Cialis (Tadalafil)||CAS 171596-29-5|
|Sildenafil Citrate()||CAS 171599-83-0|
|Vardenafil hydrochloride (Levitra)||CAS 224785-91-5|
|Dutasteride (Avodart)||CAS 164656-23-9|
|Yohimbine HCL||CAS 65-19-0|
Contact Person: Coco